Watson Pharmaceuticals announced it has initiated a search for two newly created president positions for each of the Corona, Calif.-based company’s business units – brands and generics.
As a result of this new management structure, Joseph Papa, Watson’s chief operating officer and president, will leave the company Nov. 19.
“Following our decision in June to focus on generics and specialty brand products, including urology and nephrology, we have continued to implement strategies to increase our focus in these specialty areas,” said Allen Chao, Watson’s chief executive. “We believe having a president in each business unit will enhance our ability to maximize the growth of each business.”